Linda Llewelyn Sells 1,324 Shares of Health Catalyst, Inc. (NASDAQ:HCAT) Stock

Health Catalyst, Inc. (NASDAQ:HCAT) insider Linda Llewelyn sold 1,324 shares of Health Catalyst stock in a transaction dated Monday, September 16th. The stock was sold at an average price of $8.43, for a total value of $11,161.32. Following the completion of the transaction, the insider now owns 115,599 shares in the company, valued at approximately $974,499.57. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Linda Llewelyn also recently made the following trade(s):

• On Thursday, August 15th, Linda Llewelyn sold 1,328 shares of Health Catalyst stock. The stock was sold at an average price of $6.57, for a total value of $8,724.96.
• On Monday, July 15th, Linda Llewelyn sold 1,290 shares of Health Catalyst stock. The shares were sold at an average price of $6.51, for a total value of $8,397.90.

Health Catalyst Stock Up 1.0 %

HCAT opened at $8.83 on Friday. The stock has a market cap of $521.28 million, a PE ratio of -4.77 and a beta of 1.31. The business has a 50 day moving average of $7.25 and a 200-day moving average of $6.92. Health Catalyst, Inc. has a 52 week low of $5.42 and a 52 week high of $11.41.

Health Catalyst (NASDAQ:HCAT) last announced its quarterly earnings data on Wednesday, August 7th. The company reported $0.12 EPS for the quarter, beating the consensus estimate of $0.08 by $0.04. The business had revenue of $75.90 million during the quarter, compared to analyst estimates of $74.96 million. Health Catalyst had a negative return on equity of 9.38% and a negative net margin of 28.87%. The company’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same quarter last year, the firm posted ($0.21) earnings per share. Equities analysts anticipate that Health Catalyst, Inc. will post -0.35 EPS for the current year.

Analyst Ratings Changes

Several research analysts recently commented on the stock. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $16.00 target price on shares of Health Catalyst in a research note on Tuesday, August 20th. Stephens lowered their price objective on shares of Health Catalyst from $8.00 to $7.00 and set an “equal weight” rating for the company in a research note on Thursday, August 8th. Evercore ISI dropped their target price on shares of Health Catalyst from $9.00 to $8.00 and set an “outperform” rating for the company in a report on Tuesday, July 9th. Piper Sandler lowered their price target on Health Catalyst from $14.00 to $11.00 and set an “overweight” rating for the company in a research report on Monday, August 26th. Finally, JPMorgan Chase & Co. increased their price objective on Health Catalyst from $10.00 to $13.00 and gave the stock an “overweight” rating in a report on Wednesday, September 4th. Four equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $11.42.

Institutional Investors Weigh In On Health Catalyst

Hedge funds have recently bought and sold shares of the business. Quarry LP lifted its holdings in shares of Health Catalyst by 59.4% during the second quarter. Quarry LP now owns 7,002 shares of the company’s stock valued at $45,000 after purchasing an additional 2,610 shares during the last quarter. Susquehanna Fundamental Investments LLC raised its stake in Health Catalyst by 18.3% during the second quarter. Susquehanna Fundamental Investments LLC now owns 169,529 shares of the company’s stock valued at $1,083,000 after buying an additional 26,196 shares during the last quarter. Mackenzie Financial Corp bought a new stake in Health Catalyst in the second quarter worth $70,000. The Manufacturers Life Insurance Company grew its stake in shares of Health Catalyst by 10.3% in the second quarter. The Manufacturers Life Insurance Company now owns 23,162 shares of the company’s stock worth $148,000 after acquiring an additional 2,164 shares during the last quarter. Finally, Millennium Management LLC raised its position in shares of Health Catalyst by 96.3% in the 2nd quarter. Millennium Management LLC now owns 2,413,280 shares of the company’s stock worth $15,421,000 after purchasing an additional 1,184,131 shares during the last quarter. Institutional investors own 85.00% of the company’s stock.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.